Global Autoimmune Disease Diagnostics 麻豆原创 2021-2031 by Product , Test Type , Disease Type (Systemic, Localized), Gender , Age , End User , and Region: Trend Forecast and Growth Opportunity

You are here: 麻豆原创 Catalog Pharma & Healthcare Diseases Diagnostics Country Overview (Pharma & Healthcare)

Global Autoimmune Disease Diagnostics 麻豆原创 2021-2031 by Product , Test Type , Disease Type (Systemic, Localized), Gender , Age , End User , and Region: Trend Forecast and Growth Opportunity

麻豆原创 Research Report Summary

Global Autoimmune Disease Diagnostics 麻豆原创 2021-2031 by Product , Test Type , Disease Type (Systemic, Localized), Gender , Age , End User , and Region: Trend Forecast and Growth Opportunity report is published on January 30, 2022 and has 188 pages in it. This market research report provides information about Diseases, Diagnostics, Country Overview (Pharma & Healthcare), Pharma & Healthcare industry. It covers Global market data and forecasts. It is priced starting at USD 3,100.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

Global Autoimmune Disease Diagnostics 麻豆原创 2021-2031 by Product , Test Type , Disease Type (Systemic, Localized), Gender , Age , End User , and Region: Trend Forecast and Growth Opportunity

Printer version

Send by email

Publication ID:听

GRM0122029

Publication Date:听

January 30, 2022

笔补驳别蝉:听

188

笔耻产濒颈蝉丑别谤:听

Grace 麻豆原创 Data

颁辞耻苍迟谤颈别蝉:听

Global

USD 3,100.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

Global autoimmune disease diagnostics market will reach $10.81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.
Highlighted with 87 tables and 103 figures, this 188-page report 鈥淕lobal Autoimmune Disease Diagnostics 麻豆原创 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Assay Kits & Consumables
鈥� Analyzers & Instruments

Based on Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Autoantibodies and Immunologic Tests
o Antinuclear Antibody Tests
o Anti-cyclic Citrullinated Peptide
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Rheumatoid Factor
o Thyroid Antibody Tests
o Other Autoantibodies and Immunologic Tests
鈥� Inflammatory Marker Tests
o C-Reactive Protein (CRP)
o Erythrocyte Sedimentation Rate (ESR)
o Other Inflammatory Marker Tests
鈥� Routine Laboratory Tests
o Urinalysis
o Complete Blood Count (CBC) Tests
o Other Routine Laboratory Tests
鈥� Other Test Types

Based on Disease Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Systemic Autoimmune Disease
o Rheumatoid Arthritis
o Systemic Lupus Erythematosus (SLE)
o Psoriasis/Psoriatic Arthritis
o Other Systemic Autoimmune Diseases
鈥� Localized Autoimmune Disease
o Thyroiditis
o Multiple Sclerosis
o Inflammatory Bowel Disease
o Type 1 Diabetes
o Other Localized Autoimmune Diseases

Based on Gender, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Female Patients
鈥� Male Patients

Based on Age, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� < 44
鈥� 44 - 64
鈥� > 64

Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospitals
鈥� Clinics
鈥� Diagnostic Labs
鈥� Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
鈥� North America (U.S., Canada, and Mexico)
鈥� Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
鈥� APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
鈥� South America (Brazil, Chile, Argentina, Rest of South America)
鈥� MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

1 Introduction 11
1.1 Industry Definition and Research Scope 11
1.1.1 Industry Definition 11
1.1.2 Research Scope 12
1.2 Research Methodology 15
1.2.1 Overview of 麻豆原创 Research Methodology 15
1.2.2 麻豆原创 Assumption 16
1.2.3 Secondary Data 16
1.2.4 Primary Data 16
1.2.5 Data Filtration and Model Design 17
1.2.6 麻豆原创 Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 麻豆原创 Overview and Dynamics 23
2.1 麻豆原创 Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the 麻豆原创 26
2.2 Major Growth Drivers 28
2.3 麻豆原创 Restraints and Challenges 33
2.4 Emerging Opportunities and 麻豆原创 Trends 36
2.5 Porter鈥檚 Fiver Forces Analysis 40
3 Segmentation of Global 麻豆原创 by Product 45
3.1 麻豆原创 Overview by Product 45
3.2 Assay Kits & Consumables 47
3.3 Analyzers & Instruments 48
4 Segmentation of Global 麻豆原创 by Test Type 49
4.1 麻豆原创 Overview by Test Type 49
4.2 Autoantibodies and Immunologic Tests 51
4.2.1 Antinuclear Antibody Tests 53
4.2.2 Anti-cyclic Citrullinated Peptide 54
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 55
4.2.4 Rheumatoid Factor 56
4.2.5 Thyroid Antibody Tests 57
4.2.6 Other Autoantibodies and Immunologic Tests 58
4.3 Inflammatory Marker Tests 59
4.3.1 C-Reactive Protein (CRP) 61
4.3.2 Erythrocyte Sedimentation Rate (ESR) 62
4.3.3 Other Inflammatory Marker Tests 63
4.4 Routine Laboratory Tests 64
4.4.1 Urinalysis 66
4.4.2 Complete Blood Count (CBC) Tests 67
4.4.3 Other Routine Laboratory Tests 68
4.5 Other Test Types 69
5 Segmentation of Global 麻豆原创 by Disease Type 70
5.1 麻豆原创 Overview by Disease Type 70
5.2 Systemic Autoimmune Disease 72
5.2.1 Rheumatoid Arthritis 74
5.2.2 Systemic Lupus Erythematosus (SLE) 75
5.2.3 Psoriasis/Psoriatic Arthritis 76
5.2.4 Other Systemic Autoimmune Diseases 77
5.3 Localized Autoimmune Disease 78
5.3.1 Thyroiditis 80
5.3.2 Multiple Sclerosis 81
5.3.3 Inflammatory Bowel Disease 82
5.3.4 Type 1 Diabetes 83
5.3.5 Other Localized Autoimmune Diseases 84
6 Segmentation of Global 麻豆原创 by Gender 85
6.1 麻豆原创 Overview by Gender 85
6.2 Female Patients 87
6.3 Male Patients 88
7 Segmentation of Global 麻豆原创 by Age 89
7.1 麻豆原创 Overview by Age 89
7.2 < 44 91
7.3 44 - 64 92
7.4 > 64 93
8 Segmentation of Global 麻豆原创 by End User 94
8.1 麻豆原创 Overview by End User 94
8.2 Hospitals 96
8.3 Clinics 97
8.4 Diagnostic Labs 98
8.5 Other End Users 99
9 Segmentation of Global 麻豆原创 by Region 100
9.1 Geographic 麻豆原创 Overview 2021-2031 100
9.2 North America 麻豆原创 2021-2031 by Country 104
9.2.1 Overview of North America 麻豆原创 104
9.2.2 U.S. 108
9.2.3 Canada 111
9.2.4 Mexico 113
9.3 European 麻豆原创 2021-2031 by Country 115
9.3.1 Overview of European 麻豆原创 115
9.3.2 Germany 119
9.3.3 U.K. 121
9.3.4 France 123
9.3.5 Spain 125
9.3.6 Italy 127
9.3.7 Russia 129
9.3.8 Rest of European 麻豆原创 131
9.4 Asia-Pacific 麻豆原创 2021-2031 by Country 133
9.4.1 Overview of Asia-Pacific 麻豆原创 133
9.4.2 Japan 137
9.4.3 China 140
9.4.4 Australia 142
9.4.5 India 144
9.4.6 South Korea 146
9.4.7 Rest of APAC Region 148
9.5 South America 麻豆原创 2021-2031 by Country 150
9.5.1 Argentina 153
9.5.2 Brazil 155
9.5.3 Chile 157
9.5.4 Rest of South America 麻豆原创 159
9.6 MEA 麻豆原创 2021-2031 by Country 160
9.6.1 UAE 163
9.6.2 Saudi Arabia 165
9.6.3 South Africa 167
9.6.4 Other National 麻豆原创s 169
10 Competitive Landscape 170
10.1 Overview of Key Vendors 170
10.2 New Product Launch, Partnership, Investment, and M&A 173
10.3 Company Profiles 174
Abbott Laboratories 174
Beckman Coulter, Inc. 176
Biomerieux SA 177
Bio-rad Laboratories Inc. 178
F. Hoffmann-la Roche Ltd. 179
Hemagen Diagnostics Inc. 180
Myriad Genetics Inc. 181
PerkinElmer Inc. (Euroimmun AG) 182
Quest Diagnostics Inc. 183
Siemens Healthineers Inc. 184
Thermo Fisher Scientific Inc. 185
Trinity Biotech PLC 186
Werfen Company (Inova Diagnostics Inc.) 187
RELATED REPORTS 188

Companies Covered

Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Diseases

Diagnostics

Country Overview (Pharma & Healthcare)

Pharma & Healthcare

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
Global In Vitro Diagnostics (IVD) 麻豆原创 2021-2031 by Product , Technology , Sample Type , Application , End User , and Region: Trend Forecast and Growth Opportunity Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing. Highlighted with 84 tables and 96 figures, this 194-page report 鈥淕lobal In Vitro Diagnostics (IVD) 麻豆原创 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, 麻豆原创care, POC), and...Read more	USD 3,490.00
North America In Vitro Diagnostics (IVD) 麻豆原创 2021-2031 by Product , Technology , Sample Type , Application , End User , and Country: Trend Forecast and Growth Opportunity North America in vitro diagnostics (IVD) market is projected to grow by 5.6% annually in the forecast period and reach $ 54,000.3 million by 2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing. Highlighted with 25 tables and 60 figures, this 131-page report 鈥淣orth America In Vitro Diagnostics (IVD) 麻豆原创 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and...Read more	USD 2,890.00
Europe In Vitro Diagnostics (IVD) 麻豆原创 2021-2031 by Product , Technology , Sample Type , Application , End User , and Country: Trend Forecast and Growth Opportunity Europe in vitro diagnostics (IVD) market was valued at $ 21,682.6 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing. Highlighted with 35 tables and 64 figures, this 138-page report 鈥淓urope In Vitro Diagnostics (IVD) 麻豆原创 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, 麻豆原创care, POC...Read more	USD 2,890.00
Asia Pacific In Vitro Diagnostics (IVD) 麻豆原创 2021-2031 by Product , Technology , Sample Type , Application , End User , and Country: Trend Forecast and Growth Opportunity Asia Pacific in vitro diagnostics (IVD) market will grow by 7.8% annually with a total addressable market cap of $303,673.6 million over 2022-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing. Highlighted with 35 tables and 64 figures, this 138-page report 鈥淎sia Pacific In Vitro Diagnostics (IVD) 麻豆原创 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and...Read more	USD 2,890.00
Global Minimal Residual Disease (MRD) Testing 麻豆原创 2021-2031 by Offering , Application , Technology , End User , and Region: Trend Forecast and Growth Opportunity Global minimal residual disease (MRD) testing market will reach $ 2,858.1 million by 2031, growing by 12.4% annually over 2021-2031, driven by the rising prevalence of hematological malignancy and cancer, the aging population, technological advancements in diagnostics and therapies due to increasing R&D investment, and the growing healthcare expenditure. Highlighted with 86 tables and 87 figures, this 170-page report 鈥淕lobal Minimal Residual Disease (MRD) Testing 麻豆原创 2021-2031 by Offering (Services, Test Kits & Consumables), Application (NHL, MM, ALL, CLL, AML, CML, HL, Solid Tumor), Technology (Flow Cytometry, PCR, NGS, Others), End User (Hospitals and Clinics, Research Institutions, Diagnostic Laboratories, Others), and Region: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire global minimal residual disease (MRD) testing market and all its sub-segments through extensively detailed classifications. Profound analysis and...Read more	USD 3,480.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创